Exploratory analysis of the economically justifiable price of reslizumab for asthma severe in Colombia
Abstract Introduction Asthma severe imposes important economic burden for health systems, especially with the incorporation of new drugs. Recently, reslizumab has been approved to prevent exacerbations in patients with eosinophilic asthma. This study evaluates the price at which reslizumab would be...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2025-06-01
|
| Σειρά: | BMC Public Health |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12889-025-23205-1 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|